CryoLife Inc. (CRY)
-NYSE 6.11 
0.10(1.61%) 4:07PM EDT
| Prev Close: | 6.21 |
|---|
| Open: | 6.23 |
|---|
| Bid: | 5.97 x 100 |
|---|
| Ask: | 6.49 x 6000 |
|---|
| 1y Target Est: | 6.69 |
|---|
| Beta: | 0.97 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 6.10 - 6.30 |
|---|
| 52wk Range: | 4.62 - 7.27 |
|---|
| Volume: | 35,838 |
|---|
| Avg Vol (3m): | 66,347 |
|---|
| Market Cap: | 167.84M |
|---|
| P/E (ttm): | 18.86 |
|---|
| EPS (ttm): | 0.32 |
|---|
| Div & Yield: | 0.11 (1.80%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Still Neutral on HologicZacks(Wed 1:50PM EDT)
- InPlay: CryoLife receives conditional IDE approval to begin clinical trials for PerClot in the U.S.Briefing.com(Wed 8:35AM EDT)
- CryoLife Receives Conditional IDE Approval to Begin Clinical Trials for PerClot® in the U.S.PR Newswire(Wed 8:34AM EDT)
- CryoLife receives CE Mark for HeRo Graft systemtheflyonthewall.com(Mon, Jun 10)
- CryoLife Receives CE Mark For HeRo® GraftPR Newswire(Mon, Jun 10)
- Dividend Changes To Know Now: CVR Energy, CryoLifeat Wall St. Cheat Sheet(Wed, May 29)
- CryoLife Increases Dividendat Motley Fool(Tue, May 28)
- CRYOLIFE INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Tue, May 28)
- CryoLife Increases Quarterly Cash Dividend 10 Percent for the Second Quarter 2013PR Newswire(Tue, May 28)
- DexCom Stays at NeutralZacks(Thu, May 23)
- CRYOLIFE INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Tue, May 21)
- CRYOLIFE INC FinancialsEDGAR Online Financials(Sat, May 4)
- Is Abbott a Good Defensive Play?at Wall St. Cheat Sheet(Thu, May 2)
- CryoLife's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- CryoLife Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 16.51 |
|---|
| P/S (ttm): | 1.27 |
|---|
| Ex-Dividend Date: | 12-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.27 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.07 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 5.79 |
|---|
Business Summary
CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications.
View More